Drugs / ADCTA-G
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT02772094 | May 2005 → Dec 2014 | glioblastoma | China Medical University Hospital | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ADCTA-G | “A special method has been developed for production of an immunotherapeutic, which is named "autologous dendritic cell/autologous tumor cell antigens of GBM" (ADCTA-G).” NCT02772094 ↗ |
| Modality | Vaccine | “ADCTA-G "vaccine" adjuvant immunotherapy” NCT02772094 ↗ |
| Route | Subcutaneous | “divided in 2 halves for subcutaneous injection into both axillar areas” NCT02772094 ↗ |